deltatrials
Unknown PHASE2 NCT00176397

Percutaneous Coronary Intervention (PCI) With Drug-Eluting Stents (DES) Versus Coronary Artery Bypass Graft (CABG) for Patients With Significant Left Main Stenosis

PCI With DES Versus CABG for Patients With Significant Left Main Stenosis

Sponsor: University of Leipzig

Conditions Coronary Artery Disease Coronary Stenosis
Interventions Percutaneous coronary intervention (left main)
Updated 5 times since 2017 Last updated: Sep 6, 2007 Started: Aug 31, 2003

This PHASE2 trial investigates Coronary Artery Disease and Coronary Stenosis and is currently ongoing. University of Leipzig leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Leipzig
Data source: University of Leipzig

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Leipzig, Germany